Best Investment Stock : Target we can see 500% Upside from here.Gujarat Themis Biosyn is principally engaged in the business pertaining to manufacturing of pharmaceuticals and medicinal chemicals.
Pioneer in manufacturing Rifampicin
The Company entered into Technical & Financial collaboration with Yuhan Corporation, South Korea. With Yuhan’s know-how, GTBL bec
Key stats
Market capitalization
8.969BINR
Dividends yield (FY)
1.36%
Price to earnings Ratio (TTM)
18.40
Basic EPS (TTM)
33.35INR
ISIN
INE942C01029
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
gtbl.in
Headquarters
Mumbai
Employees
105
Founded
1981
Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The firm engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.
Gujarat Themis Biosyn is out of Corrective phase & here it goes!BSE:GUJTHEM is a great counter I have been observing.
It has fabulous fundamentals being a Small Cap only BSE listed stock.
Has been undergoing multi year correction but now it is ready to break ALL TIME HIGH and contribute to Pharma rally ahead.
It supplies medicines to PHCs and CHCs of state gove
Gujarat themis biosyn trend analysisAs we can see in the chart the stock has given a breakout after a reasonably good fall over a period of time, this can be a good buy because this company makes pharmaceutical products namely rifampicin which is useful in fighting bacterial infections which might prove as the benefit due to the pande
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
Revenue